Peter D. Koch

1.3k total citations · 1 hit paper
20 papers, 679 citations indexed

About

Peter D. Koch is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Peter D. Koch has authored 20 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Peter D. Koch's work include interferon and immune responses (3 papers), Immune cells in cancer (3 papers) and Cellular transport and secretion (2 papers). Peter D. Koch is often cited by papers focused on interferon and immune responses (3 papers), Immune cells in cancer (3 papers) and Cellular transport and secretion (2 papers). Peter D. Koch collaborates with scholars based in United States, Switzerland and Germany. Peter D. Koch's co-authors include Ralph Weissleder, Timothy J. Mitchison, Mikäel J. Pittet, Firdaus S. Dhabhar, Christopher B. Rodell, Andreas Meinhardt, Xinchun Lin, Christine N. Metz, Rachel Bikoff and Richard Bucala and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Peter D. Koch

18 papers receiving 671 citations

Hit Papers

A neutrophil response linked to tumor control in immunoth... 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter D. Koch United States 11 393 231 161 64 50 20 679
Gertrud M. Hjortø Denmark 18 311 0.8× 301 1.3× 278 1.7× 68 1.1× 41 0.8× 33 743
Michael Freeley Ireland 13 202 0.5× 292 1.3× 112 0.7× 42 0.7× 84 1.7× 26 608
Meagan E. Anderson United States 8 230 0.6× 235 1.0× 89 0.6× 33 0.5× 29 0.6× 8 634
Ondřej Štěpánek Czechia 20 713 1.8× 376 1.6× 266 1.7× 27 0.4× 51 1.0× 46 1.1k
Charlene M. Downey Canada 11 287 0.7× 327 1.4× 130 0.8× 51 0.8× 74 1.5× 13 716
Abdelaziz Gdoura France 8 361 0.9× 253 1.1× 178 1.1× 43 0.7× 87 1.7× 11 740
Alexander Stratigos Greece 10 170 0.4× 164 0.7× 236 1.5× 24 0.4× 28 0.6× 23 582
Marc Llort Asens Finland 7 277 0.7× 241 1.0× 163 1.0× 66 1.0× 64 1.3× 7 707
Sara Colombetti Switzerland 16 502 1.3× 379 1.6× 261 1.6× 40 0.6× 22 0.4× 29 993
Johan Aurelius Sweden 18 559 1.4× 263 1.1× 210 1.3× 36 0.6× 15 0.3× 28 857

Countries citing papers authored by Peter D. Koch

Since Specialization
Citations

This map shows the geographic impact of Peter D. Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Koch more than expected).

Fields of papers citing papers by Peter D. Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Koch. The network helps show where Peter D. Koch may publish in the future.

Co-authorship network of co-authors of Peter D. Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Koch. A scholar is included among the top collaborators of Peter D. Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Koch. Peter D. Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henick, Brian S., Peter D. Koch, Justin F. Gainor, et al.. (2024). Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings. Journal for ImmunoTherapy of Cancer. 12(12). e009301–e009301. 4 indexed citations
2.
Gungabeesoon, Jeremy, Nicolas A. Gort-Freitas, Máté Kiss, et al.. (2023). A neutrophil response linked to tumor control in immunotherapy. Cell. 186(7). 1448–1464.e20. 229 indexed citations breakdown →
3.
Henick, Brian S., Justin F. Gainor, Mark M. Awad, et al.. (2023). Abstract CT217: 3-year update of neoadjuvant atezolizumab + chemotherapy in patients with resectable non-small cell lung cancer. Cancer Research. 83(8_Supplement). CT217–CT217. 3 indexed citations
4.
Ng, Tai L., Tae Yeon Yoo, Peter D. Koch, et al.. (2022). High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune Response. mSystems. 7(2). e0146621–e0146621. 4 indexed citations
5.
Koch, Peter D., et al.. (2021). Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells. Proceedings of the National Academy of Sciences. 118(48). 77 indexed citations
6.
Xing, Hang, Yi Song, Zhiqi Zhang, & Peter D. Koch. (2021). Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis. Journal of Molecular Neuroscience. 71(9). 1815–1824. 9 indexed citations
7.
Malek, Mouhannad, Peter D. Koch, Christian Lüchtenborg, et al.. (2021). Inositol triphosphate-triggered calcium release blocks lipid exchange at endoplasmic reticulum-Golgi contact sites. Nature Communications. 12(1). 2673–2673. 34 indexed citations
8.
Weng, Jui–Hsia, Peter D. Koch, Harding H. Luan, et al.. (2021). Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nature Metabolism. 3(4). 513–522. 65 indexed citations
9.
Weng, Jui–Hsia, Peter D. Koch, Harding H. Luan, et al.. (2021). Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nature Metabolism. 3(5). 728–728. 1 indexed citations
10.
Koch, Peter D., et al.. (2021). Small Molecule Imaging Agent for Mutant KRAS G12C. Advanced Therapeutics. 4(5). 5 indexed citations
11.
Koch, Peter D., Mikäel J. Pittet, & Ralph Weissleder. (2020). The chemical biology of IL-12 production via the non-canonical NFkB pathway. RSC Chemical Biology. 1(4). 166–176. 21 indexed citations
12.
Koch, Peter D., Christopher B. Rodell, Rainer H. Köhler, Mikäel J. Pittet, & Ralph Weissleder. (2020). Myeloid Cell-Targeted Nanocarriers Efficiently Inhibit Cellular Inhibitor of Apoptosis for Cancer Immunotherapy. Cell chemical biology. 27(1). 94–104.e5. 19 indexed citations
13.
Rodell, Christopher B., Peter D. Koch, & Ralph Weissleder. (2019). Screening for new macrophage therapeutics. Theranostics. 9(25). 7714–7729. 30 indexed citations
14.
Koch, Peter D., Maaz S. Ahmed, Rainer H. Köhler, Ran Li, & Ralph Weissleder. (2019). Imaging of Tie2 with a Fluorescently Labeled Small Molecule Affinity Ligand. ACS Chemical Biology. 15(1). 151–157. 6 indexed citations
15.
Koch, Peter D., Howard Miller, Gary Yu, et al.. (2018). A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB Signaling. ACS Chemical Biology. 13(4). 1066–1081. 17 indexed citations
16.
Koch, Peter D., et al.. (2016). Bilayer-thickness-mediated interactions between integral membrane proteins. Physical review. E. 93(4). 24 indexed citations
17.
Giedt, Randy J., Peter D. Koch, & Ralph Weissleder. (2013). Single Cell Analysis of Drug Distribution by Intravital Imaging. PLoS ONE. 8(4). e60988–e60988. 18 indexed citations
18.
Koch, Peter D., et al.. (2009). ALLESSAN CAP - A Highly Versatile And Affordable Coupling Agent. Advances in experimental medicine and biology. 611. 193–194. 1 indexed citations
19.
Koch, Peter D., et al.. (2009). ChemInform Abstract: Propylphosphonic Acid Anhydride: A Highly Expedient and Versatile Coupling Agent. ChemInform. 40(48). 1 indexed citations
20.
Fingerle‐Rowson, Günter, Peter D. Koch, Rachel Bikoff, et al.. (2003). Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo. American Journal Of Pathology. 162(1). 47–56. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026